According to data from S&P Global Market Intelligence, the stock finished last year up 28.9% on the news. As you can see from ...
Esperion (NASDAQ:ESPR) stock shot up 18% in late morning trading Monday in the wake of news that the FDA has broadened the labeling for its cardiovascular drugs Nexletol and Nexlizet. Under the new ...
Shares of Axsome Therapeutics were soaring Monday after the biopharmaceutical company announced some good news in an attempt to gain Food and Drug Administration approval of AXS-05, its drug for major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback